In the present study, we investigated the interaction between ensartinib and two main ABC drug transporters (P-gp and ABCG2) to determine the potential impact of these multidrug efflux transporters on the susceptibility of human cancer cells to ensartinib. This evidence concerns the gene PGP and cancer.